Glenview, ILNCT06062875Now EnrollingIRB Ready

Benign Prostatic Hyperplasia (BPH) Clinical Trial in Glenview, IL

Access cutting-edge benign prostatic hyperplasia (bph) treatment through this clinical trial at a research site in Glenview. Study-provided care at no cost to qualified participants.

Sponsored by Endeavor Health

Quick Self-Assessment

See if you qualify for this Glenview location

Preparing your pre-screening questions…

Expert Care in Glenview

Access benign prostatic hyperplasia (bph) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related benign prostatic hyperplasia (bph) treatment provided free

Apply for This Glenview Location

Check if you qualify for this benign prostatic hyperplasia (bph) clinical trial in Glenview, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Glenview

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Glenview site if eligible
  4. 4Begin participation

About This Benign Prostatic Hyperplasia (BPH) Study in Glenview

Specific Aim 1. To evaluate the efficacy of TNF antagonist action in BPH/LUTS Specific Aim 2. Define the consequences of TNF antagonist therapy on prostate tissue Specific Aim 3. Identify genetic predictors to stratify patients with differential response to TNF-antagonist therapy.

Sponsor: Endeavor Health

Who Can Participate

Inclusion Criteria

Age 45-80 years
Diagnosed by physician with BPH
Prostate volume ≥ 60mL
Able and willing to complete questionnaires
Able and willing to provide informed consent
Able to read, write, and speak in English
No prior treatment with TNF inhibitor (adalimumab, etanercept, infliximab, certolizumab, golimumab)
No plans to move from study area in the next 6 months Deferral Criteria:
Microscopic hematuria without appropriate workup per AUA/Society of Urodynamics, Female Pelvic Medicine \& Urogenital Reconstruction (SUFU) Guidelines
Positive urine culture

Exclusion Criteria

Female sex or intersex
Age \< 45 or \> 80 years
Being a prisoner or detainee
Urinary retention with need for catheterization
Gross hematuria
Contraindication to treatment with adalimumab (e.g., presence of sepsis or active infection, active tuberculosis, Hepatitis B infection, invasive fungal infection, lymphoma, leukemia or other active malignancy, congestive heart failure, significant hematologic abnormality, allergy to adalimumab or its components, anti-drug antibodies, congestive heart failure)
Diagnosis of autoimmune disease (rheumatoid arthritis, plaque psoriasis, ulcerative colitis, Crohn's disease, hidradenitis suppurativa, spondyloarthritis)
Interstitial cystitis
Pelvic or endoscopic genitourinary surgery within the preceding 6 months (not including diagnostic cystoscopy)
History of lower urinary tract or pelvic malignancy including prostate cancer; history of pelvic radiation therapy
Ongoing symptomatic urethral stricture
Current chemotherapy or other cancer therapy
Severe neurological or psychiatric disorder that would prevent study participation (e.g., bipolar disorder, psychotic disorder, Alzheimer's Disease)
Current moderate or severe substance use disorder

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Glenview?

Yes, this clinical trial (NCT06062875) has an active research site in Glenview, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Benign Prostatic Hyperplasia (BPH) Treatment Options in Glenview, IL

If you're searching for benign prostatic hyperplasia (bph) treatment options in Glenview, IL, this clinical trial (NCT06062875) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Glenview research site is actively enrolling participants for this clinical trial. You'll receive care from experienced benign prostatic hyperplasia (bph) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all benign prostatic hyperplasia (bph) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Glenview, IL

See all pulmonary embolism clinical trials recruiting in Glenview — not just this study.

Browse Pulmonary Embolism Trials in Glenview →

Browse More Trials by Condition

Pulmonary Embolism TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsBenign Prostatic Hyperplasia TrialsInterstitial Cystitis TrialsRetinitis Pigmentosa TrialsRecurrent Pregnancy Loss TrialsAll Conditions →

Ready to Join in Glenview?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Glenview, IL